IL-2 receptor — Drug Target

All drugs that target IL-2 receptor — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Cytokine immunotherapy · Cytokine / IL-2 receptor agonist

Phase 3 pipeline (2)

• IL2 · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · Cytokine immunotherapy · Oncology
  IL-2 (interleukin-2) is a cytokine that activates and expands T cells and natural killer cells to enhance anti-tumor immune responses.
• NL003 · Beijing Northland Biotech. Co., Ltd. · Cytokine / IL-2 receptor agonist · Oncology
  NL003 is a recombinant human IL-2 mutein that selectively activates IL-2 receptor signaling to enhance immune cell proliferation and anti-tumor activity.